• Nuevos fármacos para rescatar a los pacientes con LMC que han dejado de responder al tratamiento. Ver gaceta médica AQUI
  • Study to Evaluate the Reinduction and Second Stop of TKI With Ponatinib in CML in Molecular Response. AQUI
  • Consolidation Treatment With Ponatinib 15 mg on Treatment Free-Remission Rate in Patients With Chronic Myeloid Leukemia. AQUI.